Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Investment Ideas
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Research Tools
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
TipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Ideas
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Tools
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Technical Analysis Screener
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Auto Loan Calculator
New
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
More
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
TARA
Stock Latest News
The Fly
Guggenheim bullish on Protara after dosing of first patient in ADVANCED 2 trial
9d ago
TARA
The Fly
Protara announces dosing of first patients in Phase 1b/2 ADVANCED-2 trial
9d ago
TARA
Press Releases
Protara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
24d ago
TARA
Press Releases
Protara Therapeutics Announces Second Quarter 2023 Financial Results and Business Update
2M ago
TARA
The Fly
Protara Therapeutics expects cash to fund operations into 2025
2M ago
TARA
The Fly
Protara Therapeutics reports Q2 EPS ($1.00), consensus (80c)
2M ago
TARA
The Fly
Protara Therapeutics assumed with a Buy, $22 target at Guggenheim
3M ago
TARA
The Fly
Protara Therapeutics assumed with a Buy at Guggenheim
3M ago
TARA
Press Releases
Protara Therapeutics Announces First Quarter 2023 Financial Results and Business Update
5M ago
TARA
The Fly
Protara receive regulatory clearance from FDA to start Phase 2 STARBORN-1 trial
5M ago
TARA
The Fly
Protara Therapeutics’ TARA-002 shows early activity in NMIBC, says TD Cowen
5M ago
TARA
The Fly
Protara announces preliminary data from ADVANCED-1 Phase 1a trial
5M ago
TARA
Press Releases
Protara Therapeutics Announces Positive Preliminary Data from ADVANCED-1 Phase 1a Dose Escalation Trial of TARA-002 in NMIBC Supporting Advancement into Phase 2 Clinical Development
5M ago
TARA
Press Releases
Protara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
7M ago
TARA
The Fly
Protara Therapeutics reports Q4 EPS ($3.46), consensus (75c)
7M ago
TARA
Press Releases
Protara Therapeutics to Participate in Upcoming Investor Conferences
7M ago
TARA
Press Releases
Protara Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day
8M ago
TARA
The Fly
Protara Therapeutics announces appointment of Fabbio as CFO
8M ago
RFL
TARA
Press Releases
Protara Therapeutics Announces Appointment of Patrick Fabbio as Chief Financial Officer
8M ago
TARA
Press Releases
Protara Therapeutics Announces Trials in Progress Poster Presentation for the ADVANCED-1 Trial in NMIBC at the 23rd Annual Meeting of the Society of Urologic Oncology
10M ago
TARA
The Fly
Selecta Biosciences appoints Blaine Davis as CFO
10M ago
SELB
TARA
Press Releases
Protara Therapeutics Announces Third Quarter 2022 Financial Results and Business Overview
11M ago
TARA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
